EAAT1 Polyclonal Antibody

SLC1A3 encodes a member of a member of a high affinity glutamate transporter family. SLC1A3 functions in the termination of excitatory neurotransmission in central nervous system. Mutations are associated with episodic ataxia, Type 6. Alternative splicing results in multiple transcript variants.

The EAAT1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Excitatory Amino Acid Transporter 1 (EAAT1) protein in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional performance and reliability.

EAAT1, also known as glutamate transporter 1 (GLT-1), is a key protein involved in the regulation of glutamate homeostasis in the central nervous system. It plays a crucial role in the clearance of extracellular glutamate, preventing excitotoxicity and maintaining synaptic transmission. Dysregulation of EAAT1 has been implicated in various neurological disorders, making it an important target for research and therapeutic interventions.

The EAAT1 Polyclonal Antibody exhibits high affinity and specificity towards EAAT1, enabling accurate and precise detection of this protein in a wide range of experimental applications. It has been extensively validated for use in immunohistochemistry, immunofluorescence, western blotting, and other immunoassays.

This antibody is produced using a polyclonal approach, ensuring a diverse population of antibodies that recognize multiple epitopes on the target protein. This enhances the sensitivity and robustness of the assay, allowing for reliable and reproducible results. The antibody is purified using state-of-the-art techniques to remove any impurities, resulting in a highly pure and concentrated product.

The EAAT1 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and format, allowing for easy handling and storage. The antibody has been rigorously tested for stability and quality, ensuring consistent performance over time.

In summary, the EAAT1 Polyclonal Antibody is a valuable tool for researchers studying the role of EAAT1 in neurological disorders and glutamate homeostasis. Its high specificity, sensitivity, and reliability make it an ideal choice for a wide range of experimental applications.